Sign in
Not yet taking people in United StatesNo phase

Acetaminophen and tiredness when walking in people with multiple sclerosis

Compares acetaminophen with placebo for walking fatigue in adults with multiple sclerosis.

Key facts

Who runs it
Hunter College of City University of New York
Where
New York, United StatesSee the site
Trial code
Registry title
Effect of Acetominophen an Gait Fatigue in Multiple Sclerosis
Status
Not yet recruiting
People taking part
20 people, planned
Started
Mar 2026
Expected to end
Dec 2026
Type of study
Observational
Treatments tested
  • 1000mg acetaminophen or placebo
Record updated
17 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 with multiple sclerosis who can walk for 2 minutes in a row. It compares acetaminophen with a placebo on tiredness while walking.

Age
18 to 65 years
Sex
All sexes can join.
Disease stage
Multiple sclerosis confirmed by self-report. Must be able to walk for 2 minutes continuously, with or without an assistive device.
Earlier treatment
No recent use of steroids.
Biomarker or test result
A blood test from the last 6 months to 1 year showing normal liver and kidney results (normal liver enzymes and normal creatinine level).

Main reasons for not taking part

  • A current or recent MS flare-up (exacerbation)
  • Any bad reaction to antipyretics (fever-reducing medicines)
  • Recent use of steroids
  • Other conditions, not caused by MS, that affect walking

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • A definitive MS diagnosis confirmed by self-report,
  • The ability to walk for 2 minutes continuously with or without assistive device ---Age 18-65
  • Provide a blood test within the last 6 months to 1 year reflecting normal liver and renal profile (normal liver enzymes and normal creatinine level)

Who cannot take part

  • Recent use of steroids
  • Any non-MS conditions that interfere with walking performance
  • Any current or recent exacerbations
  • Any adverse reaction to antipyretics

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Hunter College Physical Therapy departmentNew York, United StatesContact: Herbert Karpatkion, PT, DSc, NCS, MSCSNot yet recruiting

About the trial

What the trial wants to find out

The goal of this observational study is to compare the impact of an antipyretic, acetaminophen to a placebo on gait fatigue in persons with multiple sclerosis (MS). The primary question this study is asking is the following: will the antipyretic effects of acetaminophen result in less gait fatigue in persons with MS? Participants will be asked to come for two sessions over a 1 week period. In the first week, subjects will be blind-randomized into either the acetaminophen or placebo group. They will then undergo a test to determine their gait speed by performing two 25 foot walks at their best comfortable pace. The walks will be 1 minute apart. The average speed from those 2 walks will be obtained. Subjects will then take either the acetaminophen or the placebo. Following a 45 minute rest period they will then get on a treadmill and will walk at the previously determined speed for as long as they can. Walking will stop if the subject can no longer maintain the speed or if they wish to no longer continue. The subjects will wear a safety harness at all times during the walk to prevent falls. Heart rate and core body temperature will be measured via skin sensors. One week later the subjects will return and repeat the procedure but this time in the opposite condition. Subjects who took the acetaminophen will take the placebo and subjects who took the placebo will take the acetaminophen. The difference between distance walked in the 2 conditions will be compared.

The group in the trial

  • Persons with Multiple Sclerosis

    acetaminophen or placebo

    Treatment: 1000mg acetaminophen or placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Antipyretics in Gait Fatigue in Multiple Sclerosis
Plain-language title
Acetaminophen and tiredness when walking in people with multiple sclerosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Fit questions
Built from NCT07440446, who can take part
Record updated
17 March 2026